Definitive Contract HHSN267200800020C
Award Date
9/22/08
Potential Completion Date
12/15/10
Potential Value
$150K
Awardee
Echelon Biosciences Inc.
Ultimate Awardee
Frontier Scientific, Inc.
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
AN32 - Health R&D Services; Consumer And Occupational Health And Safety; Applied Research
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, awarded a Small Business Innovation Research (SBIR) Phase II contract to Genome Explorations Inc., a minority-owned small business, for the development of a correlational alcohol-relevant database from mouse or rat transcriptome and proteome. The contract has a ceiling value of $2,282,299.92 and was awarded on September 28, 2007, with a final completion date of February 3, 2014. The contract is a...
This is a firm fixed-price purchase order contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Echelon Biosciences Inc., a small business manufacturer of goods, under the Army SBIR (Small Business Innovation Research) Phase I program. The contract has a potential value of $167,499.96 and a completion date of September 30, 2020. Echelon Biosciences Inc. is a subsidiary of Frontier Scientific, Inc., a for-profit organization that...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the National Institutes of Health (NIH), awarded a $998,800 Small Business Innovation Research (SBIR) Phase II contract to Dexorgen Inc., a minority-owned and self-certified small disadvantaged business doing business as Codex Biosolutions Inc. The contract is for the development of novel phosphodiesterase 4B (PDE4B) inhibitors to treat alcohol use disorder. This is a cost-plus-fixed-fee definitive...
This is a $800,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian federal agency, to Biorealm, LLC, a small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the development of a "Toolkit for Learning and Predicting Alcohol Use Patterns" and has a period of performance through May 10, 2025. This SBIR Phase II award follows a previous Phase I...
This is a Firm Fixed Price contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Talaria Inc., a small business contractor, under the Small Business Innovation Research (SBIR) Program Phase I. The contract, with a ceiling value of $113,644.00, is for the development of an "Adaptive Goal-Directed Adherence Tracking Enhancement" (TOPIC 033) for the National Institute on Alcohol Abuse and Alcoholism (NIAAA). The contract...
This is a firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism, a civilian federal agency, to Alc-Biosensors, LLC, a for-profit limited liability company. The contract, valued at $20,301.81, is for scientific expertise related to biosensors. The award does not have a set-aside designation, and the period of performance runs through September 30, 2016. No additional details about the specific products or services to be delivered under this contract...
This is a $20,600 firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the Department of Health and Human Services, to Enamine US Inc., a small business contractor. The contract is for single-cell RNA sequencing analysis to investigate the role of GPR110 in cell-type specific neurogenesis. This award supports the NIAAA's mission in advancing translational science and developing prevention and treatment strategies...
This federal contract award, with a ceiling value of $15,800.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services. The contract was awarded to Nemametrix, Inc., a small disadvantaged business and manufacturer of goods that specializes in developing advanced technologies for biomedical research, particularly focusing on zebrafish and C. elegans animal models. The contract, which is a...
This federal contract award, valued at $17,895.60, was issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned, for-profit organization. The contract was awarded on a firm fixed-price basis without any set-aside designations. Eurofins Discoverx Corporation, which specializes in providing innovative cell-based assays, reagents, and services to support...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Global Life Sciences Solutions USA LLC, a provider of scientific equipment, maintenance services, and medical supplies. The $24,150.60 Firm Fixed Price contract, awarded on October 17, 2017, is for a call against a Blanket Purchase Agreement (BPA) to deliver products including chromatography systems, bioreactors, freezers, and imagers to support biomedical...